# Naftin

NDC: 54766-772
Generic name: Naftifine Hydrochloride
Labeler / Manufacturer: Sebela Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20180301
Marketing ended: 20261031
FDA application: NDA204286

## Active ingredients

- NAFTIFINE HYDROCHLORIDE: 2 g/100g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54766-772"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54766-772
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6645994a-ecb3-277b-e053-2a91aa0a81e5